Bernstein's Liang on China's Edge in Pharma Sector

Bloomberg
Loading video player...
Bernstein's Liang on China's Edge in Pharma Sector
Bloomberg
Written by Bloomberg
Share

China has been closing the gap with the US in biotech and pharmaceutical research, with the proportion of studies being conducted by Chinese scientists increasing. Rebecca Liang, a senior analyst focusing on the industry at Bernstein, explains how China's biotech and healthcare sector has been developing so quickly.

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.